ADA 2016: The Future of Diabetes Drugs and Devices

ADA 2016: The Future of Diabetes Drugs and Devices

The American Diabetes Association’s 76th Scientific Sessions met in New Orleans all weekend, offering more than 300 speakers and 3,000 abstracts. Though nothing revolutionary has come out of the conference, so far, many of the presentations have featured tangible, incremental improvements in drugs, devices and clinical practice.

Read Full Article »
Comment
Show commentsHide Comments

Related Articles